{
  "compound_id": "DB00912",
  "compound_name": "Repaglinide",
  "compound_percentile": 0.816176470588235,
  "disease_id": "DOID:11054",
  "disease_name": "urinary bladder cancer",
  "disease_percentile": 0.938231469440832,
  "metapath_contribution": {
    "CbGaD": 0.6134452935187861,
    "CbGbCtD": 0.1926524229291828,
    "CbGdCrCtD": 0.0027837256552817255,
    "CbGeAlD": 0.04290881083266008,
    "CbGpPWpGaD": 0.045687673133281835,
    "CcSEcCtD": 0.10252207393080737
  },
  "n_trials": 0.0,
  "prediction": 0.0048125239603891605,
  "status": 0,
  "training_prediction": 0.0122707560061687
}